<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04792242</url>
  </required_header>
  <id_info>
    <org_study_id>SVU.MED.AIP029.4.1</org_study_id>
    <nct_id>NCT04792242</nct_id>
  </id_info>
  <brief_title>Effect of PCO2 Gap Algorithm Application on Outcome of High Risk Surgical Patients Undergoing Major Abdominal Surgeries</brief_title>
  <official_title>Comparison Between Goal Directed Therapy and PCO2 Gap Algorithm Application on Outcome of High Risk Surgical Patients Undergoing Major Abdominal Surgeries</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>South Valley University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>South Valley University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      1. Primary (main):&#xD;
&#xD;
           Comparison between goal directed therapy and PCO2 gap algorithm (carbon dioxide partial&#xD;
           pressure venous arterial gap algorithm) application on 30 days mortality and organ&#xD;
           dysfunction post operative&#xD;
&#xD;
        2. Secondary (subsidiary):&#xD;
&#xD;
      Comparison between goal directed therapy and PCO2 gap algorithm application on number of&#xD;
      ventilator dependant days, number of days on vasopressors or inotropes length of ICU stay,&#xD;
      length of hospital stay,&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      High risk surgical participants in South valley university hospitals (teaching hospitals) who&#xD;
      will undergo major abdominal surgeries will be included in research after giving written&#xD;
      informed consent from the participants or from the patient's legal representative. The use of&#xD;
      obtained data will be approved by local ethics committee.&#xD;
&#xD;
      All participants will be evaluated pre operatively and pre medicated according to protocols&#xD;
      in our hospital, base line sequential organ failure (SOFA) score will be taken. General&#xD;
      anesthesia for all patients will be carried on according to our local standards. As part of&#xD;
      our routine hemodynamic monitoring during major surgery, all patients will be monitored with&#xD;
      central venous (standard three-lumen catheter) and arterial catheters placed before the&#xD;
      beginning of surgery. The central venous line will be positioned with the tip within the&#xD;
      superior vena cava, and correct positioning will be verified by chest radiograph.&#xD;
&#xD;
      the participants will be divided randomly onto to groups using numerical system group A PCO2&#xD;
      gap algorithm(carbon dioxide partial pressure venous arterial gap) will be applied&#xD;
      intraoperative and 12 h postoperative end point PCO2 gap 2-6mm Hg(appendix 1).&#xD;
&#xD;
      Group B goal directed therapy protocol which will include targets mean arterial blood&#xD;
      pressure ( MAP) &gt; 65 mmHg, central venous pressure(CVP) between 8-12 cmH2O , Haematocrite&#xD;
      value more than 30, mixed venous oxygen saturation (Svo2) &gt;75% and urine output more than&#xD;
      &gt;0.5 ml/kg/hr and will be applied intraoperative and 12 postoperative end point base deficit&#xD;
      +/- 2(appendix 2 ).&#xD;
&#xD;
      All participants will be admitted to the ICU (intensive care unit) immediately after surgery&#xD;
      .Standard postoperative monitoring will include: electrocardiograph (heart rate), invasive&#xD;
      mean arterial pressure, pulse oxygen saturation and urine output then will be all managed&#xD;
      according to their allocated group for 12 hours.&#xD;
&#xD;
      Outcomes in both groups will be recorded which will be number of ventilator dependant days,&#xD;
      number of days on vasopressors or inotropes length of ICU stay, length of hospital stay, 30&#xD;
      days organ dysfunction, assessed by using the Sequential Organ Failure Assessment (SOFA) and&#xD;
      30 days mortality .&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 10, 2019</start_date>
  <completion_date type="Actual">March 7, 2021</completion_date>
  <primary_completion_date type="Actual">December 21, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>case control</intervention_model_description>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Post operative mortality</measure>
    <time_frame>30 days</time_frame>
    <description>early post operative mortality</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>post operative organ failure</measure>
    <time_frame>30 days</time_frame>
    <description>cardiac,renal,respiratory,renal central nervous system(CNS) failure by sequential organ failure(SOFA) score</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Major Abdominal Surgeries</condition>
  <arm_group>
    <arm_group_label>goal directed therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>svo2,haematocrite value,urine output,mean arterial pressure and central venous pressure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PCO2 gap algorithm</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>PCO2 gap,haematocrite value,Spo2,cardiac index</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>cv line insertion</intervention_name>
    <description>Svo2 and central venous pressure measurements</description>
    <arm_group_label>PCO2 gap algorithm</arm_group_label>
    <arm_group_label>goal directed therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Urinary catheter insertion</intervention_name>
    <description>urine output measurement</description>
    <arm_group_label>PCO2 gap algorithm</arm_group_label>
    <arm_group_label>goal directed therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Arterial line</intervention_name>
    <description>Arterial blood gases measurment</description>
    <arm_group_label>PCO2 gap algorithm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Clinical criteria for high-risk surgical patients used by Shoemaker and colleagues and&#xD;
             adapted by Boyd and colleagues&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  patients who will refuse to continue on research patients who will not be admitted&#xD;
             post operative in the ICU&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>South Valley University</name>
      <address>
        <city>Luxor</city>
        <state>Qena</state>
        <zip>83523</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 7, 2021</study_first_submitted>
  <study_first_submitted_qc>March 7, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 10, 2021</study_first_posted>
  <last_update_submitted>March 18, 2021</last_update_submitted>
  <last_update_submitted_qc>March 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>South Valley University</investigator_affiliation>
    <investigator_full_name>Hassan Abdelsapour Abdelrazek</investigator_full_name>
    <investigator_title>PhD Candidat</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

